trial · primary record
BL-M05D1
Locally Advanced or Metastatic Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2027-06 |
| Primary endpoint | Phase Ia: Dose limiting toxicity (DLT) |
| Registry ID | NCT06349811 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:33.518Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06349811
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Bl-m05d1 · compound